• Bradykinin BA5201: Practical Research Guide

  2026-09-17

  Bradykinin BA5201 provides a defined research peptide for investigating endothelium-dependent vasodilation, vascular permeability modulation, smooth muscle responses, pain mechanisms, and inflammation signaling. It is intended for controlled scientific workflows only; prepare solutions promptly, avoid long-term solution storage, and do not use it for diagnostic or medical purposes.

• p-tau Ser356, NUAK Inhibition, and Alzheimer’s Disease

  2026-09-17

  This study establishes p-tau Ser356 as a pathology-associated tau species that increases with Alzheimer’s disease progression and is found broadly within neurofibrillary tangles. By comparing mouse organotypic and adult human brain slice cultures, the authors show that NUAK inhibition produces model-dependent effects, with a more selective reduction of p-tau Ser356 in human tissue.

• 6-OHDA Hydrochloride in Neurodegeneration Models

  2026-09-16

  6-OHDA hydrochloride is a powerful research reagent for modeling catecholaminergic neurodegeneration. This guide explains its uptake-dependent toxicity, lesion-design choices, assay interpretation, and how protein-corona research can inform future nanoparticle delivery strategies without overstating current evidence.

• Thiazovivin (A5506): ROCK Inhibitor Workflow

  2026-09-16

  Thiazovivin is a ROCK inhibitor used to support fibroblast reprogramming and human embryonic stem cell survival during handling steps such as trypsinization. It is intended for controlled stem cell research workflows only, with concentration and exposure time requiring validation for each cell model; it is not for diagnostic, clinical, or medical use.

• Z-VEID-FMK: Decode Caspase-6-Dependent Death

  2026-09-15

  Z-VEID-FMK is a cell-permeable caspase-6 inhibitor for separating caspase-6-dependent apoptosis from pyroptotic death. This guide applies the compound to pathway-discrimination workflows inspired by recent lung cancer research, emphasizing orthogonal readouts and careful interpretation.

• Annexin V-PE Reagent: Mapping CAR-T Cell Death

  2026-09-15

  Annexin V-PE Reagent enables rapid phosphatidylserine externalization detection in CAR-T studies. This guide moves beyond simple apoptosis scoring to show how Annexin V phenotyping can resolve target-cell killing, fratricide, and effector-cell stress after CD38 binder engineering.

• Carboplatin: From DNA Damage to Translation

  2026-09-14

  Carboplatin is more than a cytotoxic benchmark: it is a translational probe for linking DNA damage, replication stress, repair capacity, and tumor-model context. This article outlines how to build better ovarian and lung cancer studies, interpret combination data, and move from product-level potency claims toward decision-ready preclinical evidence.

• Lamotrigine BBB Assay Design for CNS Research

  2026-09-14

  Lamotrigine is examined here through a translational BBB assay framework rather than a conventional mechanism summary. Learn how bidirectional transport, efflux, recovery, and lysosomal trapping controls can improve interpretation of CNS, epilepsy, and sodium-channel research.

• A1 Fluorinated CXCR4 Inhibitor in Colorectal Cancer

  2026-09-13

  Khorramdelazad et al. evaluate A1, a fluorinated CXCR4 inhibitor, through molecular simulation, CT-26 cell assays, and a BALB/c colorectal cancer model. A1 showed more favorable calculated receptor binding and stronger preclinical effects than AMD3100, including reduced tumor growth, migration, regulatory T-cell infiltration, and immunosuppressive signaling.

• CA800-PR Targets Progesterone Receptor in HR+ Breast Cancer

  2026-09-12

  The reference study introduces CA800-PR, a hydrophilic heptamethine cyanine dye designed to combine tumor targeting, near-infrared imaging, and treatment in hormone receptor-positive breast cancer. In MCF-7 cells and xenograft tumors, the dye was associated with Golgi fragmentation, selective suppression of progesterone receptor protein expression, apoptosis, cytokine production, and increased antitumor macrophage markers.

• Valemetostat: Reliable EZH1/2 Assay Design

  2026-09-11

  A scenario-driven guide to using Valemetostat (SKU BA4816) in cell viability, proliferation, and cytotoxicity workflows. It connects EZH2 biochemical potency, formulation constraints, assay controls, and vendor-selection criteria to improve interpretation and reproducibility in lymphoma research.

• Procainamide Hydrochloride: An Assay-First Guide

  2026-09-11

  Procainamide Hydrochloride is more than a cardiac sodium channel blocker: it is a versatile research probe spanning Nav1.5 electrophysiology, immune signaling, epigenetic regulation, and drug-delivery studies. This assay-first guide explains how to separate these biological readouts and interpret the influential cisplatin–liposome research without overextending its conclusions.

• Dovitinib: Chamber-Specific Assay Design

  2026-09-10

  Dovitinib (TKI-258) combines broad RTK inhibition with a useful framework for dissecting pathway-dependent apoptosis in cancer models. This article adds a distinct assay-design perspective by connecting oncology pharmacology with chamber-specific human stem cell-derived cardiomyocytes while clearly separating established evidence from testable applications.

• Laminin (925-933) Workflow for Adhesion Assays

  2026-09-10

  Laminin (925-933) is a defined Laminin B1 chain peptide for separating peptide-mediated cell attachment and chemotaxis from the broader complexity of full-length laminin. This guide covers stock preparation, adhesion and migration assay setup, controls, and limitations; it is intended for research workflows only, not diagnostic, therapeutic, or clinical use.

• JNJ-10198409: A Systems-Level PDGF Assay Strategy

  2026-09-09

  JNJ-10198409 is a platelet-derived growth factor receptor inhibitor suited to mechanistic studies of ATP-competitive kinase blockade, proliferation, and angiogenesis. This article develops an assay strategy that connects PDGF-BB target engagement with the stage-dependent signaling logic revealed by recent host–pathogen research.

8538 records 1/570 page Next 12345 下5页 Last page